The Management of Eosinophilic Gastroenteritis

Authors

• Nancy Gupta
• Arun Aggarwal
• Rahul Gupta
• Sachin Sule, New York Medical CollegeFollow
• David Wolf, New York Medical CollegeFollow

Author Type(s)

Faculty

DOI

10.3109/00365521.2015.1049655

Journal Title

Scandinavian Journal of Gastroenterology

First Page

1309

Last Page

1314

Document Type

Article

Publication Date

1-1-2015

Department

Medicine

Keywords

Adrenal Cortex Hormones, Diet Therapy, Disease Management, Enteritis, Eosinophilia, Gastritis, Humans, Immunosuppressive Agents, Immunotherapy, Randomized Controlled Trials as Topic, United States, United States Food and Drug Administration

Disciplines

Medicine and Health Sciences

Abstract

Eosinophilic gastroenteritis (EG) is a rare disorder characterized by eosinophilic infiltration of the gastrointestinal tract. No medication at present is approved by the Food and drug administration of United States for the treatment of EG. The rarity of the disease limits our experience with the different management options. It also limits the ability to conduct randomized controlled trials that could clearly delineate the efficacy of new therapeutic agents. This review assesses the various management options that have been tried on patients with EG.

Recommended Citation

Gupta, N., Aggarwal, A., Gupta, R., Sule, S., & Wolf, D. (2015). The Management of Eosinophilic Gastroenteritis. Scandinavian Journal of Gastroenterology, 50 (11), 1309-1314. https://doi.org/10.3109/00365521.2015.1049655